EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of probiotics in modulation of the gut-brain axis: a prospective therapy for depression and mood disorders

Hui Wang, Yining Chen, Allen Zhao, Zhongxia Shen, Yu Zhang

Frontiers in Pharmacology · 26.01.2026 · 16

DOI: 10.3389/fphar.2025.1709060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.01.2026. Verfasst von Hui Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 248 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut-brain axis is a bidirectional pathway linking the gastrointestinal microbiota to neurological functions. While its significance in the pathogenesis of gastrointestinal conditions is well-documented, emerging evidence indicates that dysbiosis of the gut microbiota could also be implicated in various neuropsychiatric disorders, specifically major depressive disorder (MDD). MDD represents a debilitating illness that accounts for a significant portion of global disability. Although numerous medications have been developed to manage depression, they are frequently plagued by variable efficacy and unpleasant adverse effects. The inconsistency of antidepressant effects highlights the complexity and poorly understood pathophysiology underlying this condition. Recent studies suggest that MDD may involve disruptions in the gut-brain axis via gut dysbiosis, induction of inflammation, metabolic disturbances of neuroactive substances, and dysregulation of the hypothalamic-pituitary-adrenal axis, along with the autonomic and enteric nervous systems. Given the direct and indirect connections between the microbiota and these physiological processes, probiotics are increasingly being explored as a prospective therapeutic option for MDD. Multiple probiotic formulations have shown promise in both preclinical and clinical settings, demonstrating effectiveness in attenuating symptoms associated with MDD. This review provides an overview of the pathophysiologic attributes of MDD, with particular focus on disturbances along the gut-brain axis, and investigates current findings regarding the role of probiotics in addressing these challenges. We conclude by identifying persistent gaps in the literature and proposing directions for future studies.

Schlagwörter

Stichwörter der Autor:innen

gut-brain axishypothalamic-pituitary-adrenal axismajor depressive disordermicrobiotaprobiotics

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, China.
  • Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Rutgers Biomedical and Health Sciences, Piscataway, NJ, United States.
  • The Experimental High School Attached to Beijing Normal University, Beijing, China.
  • Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, WI, United States.
  • Department of Sleep Medical Center, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, China.
  • Department of Gastroenterology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Wang, H., Chen, Y., Zhao, A., Shen, Z., & Zhang, Y. (2026). The role of probiotics in modulation of the gut-brain axis: a prospective therapy for depression and mood disorders. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1709060

Vancouver

Wang H, Chen Y, Zhao A, Shen Z, Zhang Y. The role of probiotics in modulation of the gut-brain axis: a prospective therapy for depression and mood disorders. Frontiers in Pharmacology. 2026;16. doi:10.3389/fphar.2025.1709060

BibTeX
@article{Wang2026,
  author = {Wang, Hui and Chen, Yining and Zhao, Allen and Shen, Zhongxia and Zhang, Yu},
  title = {The role of probiotics in modulation of the gut-brain axis: a prospective therapy for depression and mood disorders},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fphar.2025.1709060}
}
Kostenlos starten →